share_log

Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Arizona State Retirement System

Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Arizona State Retirement System

AXON企业公司(纳斯达克代码:AXON)亚利桑那州退休系统购买的股票
Defense World ·  2022/07/31 18:21

Arizona State Retirement System grew its position in Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 4.7% in the first quarter, Holdings Channel.com reports. The fund owned 18,508 shares of the biotechnology company's stock after buying an additional 832 shares during the period. Arizona State Retirement System's holdings in Axon Enterprise were worth $2,549,000 as of its most recent filing with the Securities and Exchange Commission.

据Holdings Channel.com报道,今年第一季度,亚利桑那州退休系统在Axon Enterprise,Inc.(纳斯达克代码:Axon-Get Rating)的持仓增加了4.7%。该基金持有这家生物技术公司18,508股股票,在此期间又购买了832股。截至最近提交给美国证券交易委员会(Securities And Exchange Commission)的文件,亚利桑那州退休系统在Axon Enterprise持有的股份价值254.9万美元。

A number of other institutional investors have also made changes to their positions in the company. Vaughan Nelson Investment Management L.P. bought a new stake in shares of Axon Enterprise in the 1st quarter valued at approximately $12,825,000. State of New Jersey Common Pension Fund D grew its stake in Axon Enterprise by 6.8% during the 1st quarter. State of New Jersey Common Pension Fund D now owns 40,534 shares of the biotechnology company's stock worth $5,583,000 after buying an additional 2,567 shares during the last quarter. Securian Asset Management Inc. grew its stake in Axon Enterprise by 3.7% during the 1st quarter. Securian Asset Management Inc. now owns 6,144 shares of the biotechnology company's stock worth $846,000 after buying an additional 220 shares during the last quarter. Calamos Advisors LLC grew its stake in Axon Enterprise by 17.6% during the 1st quarter. Calamos Advisors LLC now owns 23,963 shares of the biotechnology company's stock worth $3,300,000 after buying an additional 3,594 shares during the last quarter. Finally, Mutual of America Capital Management LLC grew its stake in Axon Enterprise by 5.9% during the 1st quarter. Mutual of America Capital Management LLC now owns 65,417 shares of the biotechnology company's stock worth $9,010,000 after buying an additional 3,648 shares during the last quarter. 72.06% of the stock is currently owned by institutional investors.

其他一些机构投资者也改变了他们在该公司的头寸。沃恩·纳尔逊投资管理公司在第一季度购买了Axon Enterprise的新股份,价值约为12,825,000美元。新泽西州共同养老基金D在第一季度增加了其在Axon Enterprise的股份6.8%。新泽西州共同养老基金D现在拥有40,534股这家生物技术公司的股票,价值5,583,000美元,上个季度又购买了2,567股。Securian Asset Management Inc.在第一季度增持了Axon Enterprise 3.7%的股份。Securian Asset Management Inc.现在持有这家生物技术公司6,144股股票,价值84.6万美元,该公司在上个季度又购买了220股。第一季度,Calamos Advisors LLC在Axon Enterprise的持股增加了17.6%。Calamos Advisors LLC现在拥有这家生物技术公司23,963股股票,价值330万美元,在上个季度又购买了3594股。最后,美国互惠资本管理公司第一季度在Axon Enterprise的持股增加了5.9%。美国互惠资本管理公司现在持有这家生物技术公司65,417股股票,价值9,01万美元,在上个季度又购买了3,648股。72.06%的股票目前由机构投资者持有。

Get
到达
Axon Enterprise
Axon企业
alerts:
警报:

Axon Enterprise Stock Up 2.1 %

Axon企业股票上涨2.1%

Shares of Axon Enterprise stock opened at $110.19 on Friday. The stock has a 50-day moving average price of $95.39 and a 200 day moving average price of $113.99. The company has a market cap of $7.82 billion, a P/E ratio of 211.91 and a beta of 0.61. The company has a current ratio of 2.43, a quick ratio of 2.18 and a debt-to-equity ratio of 0.02. Axon Enterprise, Inc. has a 1 year low of $82.49 and a 1 year high of $209.00.

上周五,Axon Enterprise的股票开盘报110.19美元。该股的50日移动均线价格为95.39美元,200日移动均线价格为113.99美元。该公司市值为78.2亿美元,市盈率为211.91,贝塔系数为0.61.该公司的流动比率为2.43,速动比率为2.18,债务权益比率为0.02。Axon Enterprise,Inc.的一年低点为82.49美元,一年高位为209.00美元。

Axon Enterprise (NASDAQ:AXON – Get Rating) last issued its earnings results on Tuesday, May 10th. The biotechnology company reported $0.76 earnings per share for the quarter. Axon Enterprise had a return on equity of 3.90% and a net margin of 4.62%. The company had revenue of $256.43 million for the quarter, compared to analyst estimates of $233.57 million. During the same period in the prior year, the firm posted ($0.75) EPS. The business's revenue was up 31.5% compared to the same quarter last year. As a group, analysts expect that Axon Enterprise, Inc. will post 1.35 EPS for the current fiscal year.
Axon Enterprise(纳斯达克:Axon-Get Rating)最近一次发布财报是在5月10日(星期二)。这家生物技术公司公布本季度每股收益为0.76美元。Axon Enterprise的股本回报率为3.90%,净利润率为4.62%。该公司本季度营收为2.5643亿美元,而分析师预期为2.3357亿美元。去年同期,该公司公布的每股收益为0.75美元。与去年同期相比,该业务的收入增长了31.5%。分析人士预计,作为一个整体,Axon Enterprise,Inc.本财年每股收益将达到1.35欧元。

Insiders Place Their Bets

内部人士下注

In other news, Director Mark W. Kroll sold 3,159 shares of the stock in a transaction dated Wednesday, June 8th. The stock was sold at an average price of $102.82, for a total transaction of $324,808.38. Following the transaction, the director now owns 13,691 shares of the company's stock, valued at approximately $1,407,708.62. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 6.90% of the company's stock.

其他新闻方面,董事马克·克罗尔在一笔日期为6月8日(星期三)的交易中出售了3159股该公司股票。该股以102.82美元的平均价格出售,总成交金额为324,808.38美元。交易完成后,董事现在持有该公司13,691股股票,价值约1,407,708.62美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的,通过这个超级链接可以访问微博。内部人士持有该公司6.90%的股份。

Analysts Set New Price Targets

分析师设定新的价格目标

AXON has been the subject of a number of recent research reports. Northland Securities lowered their price objective on Axon Enterprise from $180.00 to $130.00 in a research note on Thursday, May 12th. Morgan Stanley cut Axon Enterprise from an "overweight" rating to an "equal weight" rating and set a $120.00 price target for the company. in a research note on Monday, May 23rd. JMP Securities reissued a "buy" rating and issued a $195.00 price target on shares of Axon Enterprise in a research note on Wednesday, June 1st. Robert W. Baird decreased their price target on Axon Enterprise from $145.00 to $125.00 in a research note on Wednesday, May 11th. Finally, Credit Suisse Group decreased their price target on Axon Enterprise from $169.00 to $134.00 in a research note on Thursday, July 14th. One equities research analyst has rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $169.00.

轴突是最近一些研究报告的主题。Northland Securities在5月12日星期四的一份研究报告中将Axon Enterprise的目标价从180.00美元下调至130.00美元。摩根士丹利将Axon Enterprise的评级从“增持”下调至“持平”,并为该公司设定了120.00美元的目标价.在5月23日星期一的一份研究报告中。JMP证券在6月1日星期三的一份研究报告中重新发布了“买入”评级,并对Axon Enterprise的股票发布了195.00美元的目标价。罗伯特·W·贝尔德在5月11日星期三的一份研究报告中将Axon Enterprise的目标价从145.00美元下调至125.00美元。最后,瑞士信贷集团在7月14日星期四的一份研究报告中将Axon Enterprise的目标价从169.00美元下调至134.00美元。一位股票研究分析师将该股的评级定为持有,8位分析师给出了买入评级,一位分析师给出了强烈的买入评级。根据MarketBeat.com的数据,该股目前的共识评级为买入,共识目标价为169.00美元。

About Axon Enterprise

关于Axon Enterprise

(Get Rating)

(获取评级)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Axon Enterprise,Inc.在美国和国际上以泰瑟品牌开发、制造和销售导电能源设备(CED)。它通过两个部分运作,泰瑟枪和软件和传感器。该公司还提供硬件和基于云的软件解决方案,使执法部门能够捕获、安全存储、管理、共享和分析视频和其他数字证据。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on Axon Enterprise (AXON)
  • Procter's Earnings Start To Show Weakness In Q4
  • MarketBeat: Week in Review 7/25 – 7/29
  • The One Question You Have to Ask Before Investing in INTC Stock
  • Home Depot: A Beautiful Boring Stock to Navigate a Bear Market
  • Could CRISPR Therapeutics be a Moonshot Hiding in Plain Sight?
  • 免费获取StockNews.com关于Axon Enterprise(Axon)的研究报告
  • 宝洁第四季度收益开始疲软
  • MarketBeat:回顾一周7/25-7/29
  • 在投资INTC股票之前,你必须问一个问题
  • 家得宝:引领熊市的美丽而乏味的股票
  • CRISPR治疗公司可能是隐藏在平坦视线中的登月计划吗?

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating).

想看看还有哪些对冲基金持有Axon吗?访问HoldingsChannel.com获取Axon Enterprise,Inc.(纳斯达克:Axon-Get Rating)的最新13F备案和内幕交易信息。

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.

接受Axon企业日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收Axon Enterprise和相关公司的最新新闻和分析师评级的每日简明摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发